Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Convalescent Plasma for Severe COVID-19
NCT04340050Phase 1Completed
- Sponsor
- University of Chicago
- Start
- Apr 2020
- Primary completion
- Dec 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by University of Chicago. Primary endpoints: Success of Administering Plasma and Type of Respiratory Support. Started Apr 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04340050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04340050.